Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc.

ENSCNASDAQ

Ensysce Biosciences, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Dr. Lynn Kirkpatrick, with a market cap of $5.2M. As of Q3 2025, 12% of shares are held by 16 institutional investors, with PERCEPTIVE ADVISORS LLC as the largest holder at 2.92%.

Chief Executive OfficerDr. Lynn Kirkpatrick
Market Cap$5.2M
Biotechnology
Healthcare
Employees8.0
Country
United States of America

Overview

Overview of institutional ownership in ENSC as of Q3 2025 with a market cap of $7.0M

All Institutions

Institutions
16
Value Held
$826.4K
Shares Held
348.7K
Avg Position
$51.7K
Median Position
$28.4K

Hedge Funds

Hedge Funds
3
Value Held
$276.7K
Shares Held
116.8K
Avg Position
$92.2K
Median Position
$36.9K

Ownership Breakdown

Institutional (non-HF): 7.81%Hedge Funds: 3.93%Retail & Other: 88.25%Retail & Other
Institutional (non-HF)
7.81%
$549.7K
Hedge Funds
3.93%
$276.7K
Retail & Other
88.25%
$6.2M

Based on market cap of $7.0M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in ENSC as of Q3 2025

InstitutionPosition Value
PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
$205.4K
0.01% of portfolio
$177.1K
0.00% of portfolio
$163.9K
0.01% of portfolio
$87.0K
0.00% of portfolio
$36.9K
0.00% of portfolio
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$34.4K
0.00% of portfolio
$33.7K
0.00% of portfolio
$30.9K
0.00% of portfolio
X
XTX Topco Ltd
Institution
$26.0K
0.00% of portfolio
$24.9K
0.02% of portfolio

Net Capital Flow

Institutional buying and selling activity for ENSC in Q3 2025

Traded
+$409.0K
Buyers
11
Sellers
4
Total Bought
+$414.6K
Total Sold
$5.6K
Avg Position
$45.9K

Biggest Buyers

InstitutionNet Bought
+$163.9K
+69.1K shares
+$87.0K
+36.7K shares
+$36.9K
+15.6K shares
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
+$34.4K
+14.5K shares
+$33.7K
+14.2K shares
X
XTX Topco Ltd
Institution
+$26.0K
+11.0K shares
+$24.9K
+10.5K shares
+$6.8K
+2.9K shares
UBS Group AG logo
UBS Group AG
Institution
+$1.1K
+446.0 shares
+$31.0
+13.0 shares

Biggest Sellers

InstitutionNet Sold
$4.5K
1.9K shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$843.0
378.0 shares
$210.0
94.0 shares
$49.8
21.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited ENSC in Q3 2025

New Positions
3
New Value
$188.8K
Exited Positions
2
Exited Value
$1.1K

New Positions

InstitutionPosition Value
$163.9K
69.1K shares
$24.9K
10.5K shares
$31.0
13.0 shares

Exited Positions

InstitutionPrevious Position
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$843.0
378.0 shares
$210.0
94.0 shares

Options Activity

Institutions with the largest Call and Put options positions in ENSC as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with ENSC as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
0.02%
$24.9K
0.01%
$163.9K
PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
0.01%
$205.4K
0.00%
$33.7K
X
XTX Topco Ltd
Institution
0.00%
$26.0K
0.00%
$177.1K
0.00%
$3.2K
0.00%
$36.9K
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
0.00%
$34.4K
0.00%
$991.0

Hedge Fund Spotlight

Discover hedge funds investing in ENSC

PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
Portfolio ManagerJoseph Eric Edelman
Portfolio Value
$3.5B
Positions
90
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Healthcare: 81.80%Healthcare
Ensysce Biosciences, Inc. logo

Position in Ensysce Biosciences, Inc.

Market Value
$205.4K
Shares Held
86.7K
Portfolio Weight
0.01%
Owned Since
2024-Q4
Top HoldingSectorMarket ValueWeight
Biotechnology
Healthcare
$288.4M8.35%
Unknown
Unknown
$216.4M6.27%
Biotechnology
Healthcare
$202.7M5.87%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.